Cargando…

The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors

The 2021 5th edition of the WHO Classification of Tumors of the Central Nervous System reflects the discovery of genetic alterations underlying many central nervous system (CNS) neoplasms. Insights gained from technologic advances and novel applications in molecular diagnostics, including next‐gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bale, Tejus A., Rosenblum, Marc K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Invited Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245930/ https://www.ncbi.nlm.nih.gov/pubmed/35218102 http://dx.doi.org/10.1111/bpa.13060

Ejemplares similares

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
por: Sahm, Felix, et al.
Publicado: (2023)

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond
por: Kresbach, Catena, et al.
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System
por: Zhao, Zheng, et al.
Publicado: (2022)

The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know—a minireview
por: Torp, Sverre Helge, et al.
Publicado: (2022)

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update
por: Whitfield, Benjamin T., et al.
Publicado: (2022)

Papillary glioneuronal tumor: a new entity awaiting inclusion in WHO classification
por: Radotra, BD, et al.
Publicado: (2007)

Neuroimaging of pediatric tumors of the sellar region—A review in light of the 2021 WHO classification of tumors of the central nervous system
por: Maia, Rúben, et al.
Publicado: (2023)

FGFR- gene family alterations in low-grade neuroepithelial tumors
por: Bale, Tejus A.
Publicado: (2020)

Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system
por: Yang, Chenlong, et al.
Publicado: (2017)

Clinical and molecular features of disseminated pediatric low-grade glioma and glioneuronal tumors: a systematic review and survival analysis
por: Haizel-Cobbina, Joseline, et al.
Publicado: (2022)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
por: Tsukamoto, Taro, et al.
Publicado: (2023)

RARE-37. NOONAN SYNDROME AND GLIONEURONAL TUMORS: A CENTRAL NERVOUS SYSTEM CANCER PREDISPOSITION ASSOCIATION?
por: Shatara, Margaret, et al.
Publicado: (2020)

Pediatric high-grade gliomas and the WHO CNS Tumor Classification—Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates
por: Gielen, Gerrit H, et al.
Publicado: (2022)

The clinical and pathological features of low-grade epilepsy-associated glioneuronal tumors
por: Xie, Mingguo, et al.
Publicado: (2022)

Use of circulating tumor DNA to guide treatment of primary central nervous system lymphoma: a case report
por: Ho, Ka-wai Grace, et al.
Publicado: (2021)

METB-07. MINIMALLY-INVASIVE DIAGNOSIS OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) USING CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING IN PEDIATRIC AND YOUNG ADULT PATIENTS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

The WHO classification of tumors of the central nervous system‐finally here, and welcome!
por: Rodriguez, Fausto J.
Publicado: (2022)

Embryonal and non‐meningothelial mesenchymal tumors of the central nervous system – Advances in diagnosis and prognostication
por: Meredith, David M., et al.
Publicado: (2022)

Focal Epilepsy Associated with Glioneuronal Tumors
por: Loiacono, Giulia, et al.
Publicado: (2011)

An Individual Patient Data Meta-Analysis on Characteristics and Outcome of Patients with Papillary Glioneuronal Tumor, Rosette Glioneuronal Tumor with Neuropil-Like Islands and Rosette Forming Glioneuronal Tumor of the Fourth Ventricle
por: Schlamann, Annika, et al.
Publicado: (2014)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

LGG-14. TREATMENT OF TWO PEDIATRIC FGFR-ALTERED LOW-GRADE GLIONEURONAL TUMORS WITH MEK INHIBITION
por: Lazow, Margot, et al.
Publicado: (2023)

Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report
por: Tadipatri, Ramya, et al.
Publicado: (2022)

Tumors of the Central Nervous System: An Update
por: Mucignat-Caretta, Carla
Publicado: (2020)

Central nervous system effects of tumor necrosis factor alpha blockade
por: Schett, Georg
Publicado: (2011)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Rosette-forming glioneuronal tumor of the fourth ventricle
por: Kumar, Manoj, et al.
Publicado: (2015)

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
por: Wang, Yaning, et al.
Publicado: (2023)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

A simplified overview of the World Health Organization classification of central nervous system tumors 2021
por: Prajapati, Hanuman Prasad, et al.
Publicado: (2022)

Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas
por: Benhamida, Jamal K., et al.
Publicado: (2023)

Updates on the 2016 World Health Organization Classification of Pediatric Tumors of the Central Nervous System - a systematic review
por: Cosnarovici, Maria Margareta, et al.
Publicado: (2021)

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection
por: Capper, David, et al.
Publicado: (2023)

A glioneuronal tumor with CLIP2-MET fusion
por: Chowdhury, Tamrin, et al.
Publicado: (2020)

LINC-09. Coexisting glioneuronal tumor and adrenal ganglioneuroma
por: Shahbandi, Ataollah, et al.
Publicado: (2022)

Diffuse leptomeningeal glioneuronal tumor with high-grade features masquerading as tubercular meningitis—a case report
por: Peer, Sameer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vnrtc1fujkn5j93pso77i7cq41